← Back
Data updated: Mar 10, 2026
PENN LIFE
Oncology
PENN LIFE is a generic drug manufacturer focused on Oncology. Key products include CARMUSTINE.
2019
Since
4
Drugs
-
Trials
8
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
ARSENIC TRIOXIDE 2026-01-30
Labeling
ISOPROTERENOL HYDROCHLORIDE 2025-12-10
ISOPROTERENOL HYDROCHLORIDE 2024-10-03
ISOPROTERENOL HYDROCHLORIDE 2024-08-22
Labeling
THIOTEPA 2024-08-20
ISOPROTERENOL HYDROCHLORIDE 2024-08-06
ARSENIC TRIOXIDE 2024-07-08
Labeling
THIOTEPA 2024-05-30
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Oncology 100%
2 drugs
Pipeline Strength Pro
Loading...
Active (2)
Discontinued (2)
Company Info
- First Approval
- 2019-04-02
- Latest
- 2022-09-20
- Applications
- 4